ARYL hydrocarbon hydroxylase (AHH)
is an enzyme system found in many tissues and organs within the human body, as well as in various mammalian cells, and which is involved in metabolism of polynuclear aromatic hydrocarbons (PAHs) to more polar derivatives (Heidelberger, 1975) . In the case of the metabolism of PAHs such as benzo(a)pyrene (BP) it is thought that one or more of the metabolites is (are) the actual carcinogen(s) (Sims and Grover, 1974; Gelboin et al., 1976; Weinstein et al., 1976; Marquardt, 1977) . Using the originally proposed method of Wattenberg et al. (1968) , Nebert and Gelboin (1968) developed a fluorimetric assay for AHH activity, using liver microsomes for converting BP into 3-hydroxybenzo(o)pyrene (3-BPOH). Several reports have shown that AHH, a mixed-function oxidase, is induced in various tissues by PAHs, drugs, steroids, insecticides and other compounds (Conney, 1967; Nebert and Gelboin, 1968; Nebert, 1971 , 1972; Lu et al., 1972) . Various authors have demonstrated AHH activity in human lymphocytes (Whitlock et al., 1972; Busbee et al., 1972; Kellermann et al., 1973a, b and c; Bast et al., 1976) and have used BP with cultured lymphocytes to determine the AHH activity by fluorimetric measurement of the amount of 3-BPOH formed. The fluorimetric method for AHH activity in human lymphocytes has created much interest as a relatively simple screening test for susceptibility to bronchogenic cancer (Kellermann et al., 1973b, c and d) as caused by either cigarette smoking or various other chemical agents (Alfred and Bowens, 1975) . Nevertheless, the test does not appear very reproducible either in a single laboratory or between laboratories (Paigen et al., 1977; Cantelli Forti et al., 1977) . Hence, many variants of the original fluorimetric method of Wattenberg et al. (1968) and Nebert and Gelboin (1968) have been published by different workers in an attempt to improve its reproducibility and accuracy (Whitlock et al., 1972; Busbee et al., 1972; Kellermann et al., 1973a, band c; Dehnen et al., 1973; Gurtoo et al., 1975; Cantrell et al., 1976; Bast et al., 1976; Paigen et al., 1977 ([G-3H] BP) (Amersham/Searle Co; sp. act. 5 Ci/ mmol; 20 mCi/mg; radioactive concentration, 5 mCi//ml in benzene; BP concentration, 0-250 mg/ml) were purified by thinlayer chromatography 2-dimensionally on silica gel G (Merck pre-coated plates) using first, benzene and then 1:15 (v/v) benzene: hexane. The major, 0 90 Rf, fraction was retained and an acetone stock solution was prepared for the experiments.
Incubation of the test tubes was carried out in a shaking bath at 37+0 050C for 30 min. At the end of this time, 4 ml of 25% acetone in hexane was added. The tubes were mixed on a vortex for 1 min and the phases separated by centrifugation at 400 g for 3 min.
The buffered aqueous phase (A) was recovered and transferred directly into a liquid-scintillation vial containing 10 ml of PCSTM cocktail (Phase Combining SystemTRADE MARK Amersham/Searle Co.). The organic phase was vortexed in another test tube with 1 ml of IN NaOH. After additional mixing for 1 min and centrifugation, the phases were separated. The organic phase (B) and the NaOH phase (C) were each transferred into 10 ml of PCSTM cocktail in liquid-scintillation vials.
Standards of buffer mixture, hexane: acetone (1: 3 v/v) mixture, IN NaOH and BP solution (unlabelled) were added separately to 10 ml of PCSTM cocktail, to obtain the quenching calibration curves. A Beckman model LS-100 was used for radioactive measurements. All experiments were made using yellow light, because of the observed and widely known photo-decomposition of BP and its metabolites. Fluorescence spectra were obtained on a Perkin-Elmer Model MPF-2A, using an excitation wavelength of 396 nm. Table I shows the percentage of total radioactivity found in the various phases, using the procedure of Kellermann et al. (1973a, and b) in the absence of human lymphocytes but with [G-3H]BP. The most significant fact is that 11.72% of the total radioactivity ends up in the NaOH phase (C), while the method was developed to ensure that no BP, only 3-BPOH, was being extracted by the NaOH. It should be noted that the total recovery of radioactivity is 98 89%, suggesting minimal error due to losses.
On the basis of the data in Table I (1975) . Data on the presence of other metabolites as detected by radioisotopic assay developed by us will be presented elsewhere (Cantelli Forti et al., 1977) .
In summary, the fluorimetric procedure such as that of Kellermann et al. (1973a and b) for AHH inducibility in human lymphocytes has a number of inherent problems. These are: (1) the extraction of BP along with 3-BPOH, and probably other metabolites, and their fluorimetric interference, (2) the photochemical instability of the BP, 3-BPOH and other metabolites which may lead to additional errors if proper precautions are not taken. This paper emphasizes the first point.
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